Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Extends License to Gene Logic s ToxExpress Database

NEW YORK, Oct. 4 - Gene Logic of Gaithersburg, Md., said Thursday that Pfizer had extended it subscription to Gene Logic's ToxExpress database module. 

Pfizer, which has had access to ToxExpress since 2000, extended its total subscription term to five years. 

Gene Logic did not disclose financial terms of the deal. 

In January, Gene logic and Pfizer announced an agreement to jointly develop a microarray for toxicology studies using Affymetrix’s GeneChip technology.

Under the agreement, Gene Logic and Pfizer researchers said they would design the array, while Affymetrix would build it. The array will only be available to subscribers of Gene Logic’s ToxExpress and is designed to complement the ToxExpress’s library of toxicity markers.   

ToxExpress is a module in the GeneExpress suite of databases. It offers data on the effects of more than 10 toxic compounds on the liver, kidney, bone marrow, and heart of animals.

 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more